Literature DB >> 16974201

Perospirone is a new generation antipsychotic: evidence from a positron emission tomography study of serotonin 2 and D2 receptor occupancy in the living human brain.

Yoshimoto Sekine, Yasuomi Ouchi, Nori Takei, Etsuji Yoshikawa, Hiroyuki Okada, Yoshio Minabe, Kazuhiko Nakamura, Katsuaki Suzuki, Yasuhide Iwata, Kenji J Tsuchiya, Genichi Sugihara, Norio Mori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16974201     DOI： 10.1097/01.jcp.0000236659.93415.4a

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  3 in total

1.  Dopamine D2 receptor occupancy by perospirone: a positron emission tomography study in patients with schizophrenia and healthy subjects.

Authors:  Ryosuke Arakawa; Hiroshi Ito; Akihiro Takano; Masaki Okumura; Hidehiko Takahashi; Harumasa Takano; Yoshiro Okubo; Tetsuya Suhara
Journal:  Psychopharmacology (Berl)       Date:  2010-03-27       Impact factor: 4.530

2.  Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial.

Authors:  Yoshiteru Takekita; Chiara Fabbri; Masaki Kato; Shinpei Nonen; Shiho Sakai; Naotaka Sunada; Yosuke Koshikawa; Masataka Wakeno; Gaku Okugawa; Toshihiko Kinoshita; Alessandro Serretti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-05-28       Impact factor: 5.270

3.  Effect of the novel antipsychotic drug perospirone on P-glycoprotein function and expression in Caco-2 cells.

Authors:  Yan-Gang Zhou; Kun-Yan Li; Huan-De Li
Journal:  Eur J Clin Pharmacol       Date:  2008-05-14       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.